Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Momburg

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Immunology|May 21, 2022
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-EClaire Battin, Gabriel Kaufmann, Judith Leitner, et al.
Cancers|January 8, 2025
Reversal of Endothelial Cell Anergy by T Cell-Engaging Bispecific AntibodiesMárcia Gonçalves, Karsten M Warwas, Marten Meyer, et al.
Plos One|November 7, 2008
The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1Irini Evnouchidou, Frank Momburg, Athanasios Papakyriakou, et al.
EMBO Reports|October 16, 2020
MLLT6 maintains PD-L1 expression and mediates tumor immune resistanceSandeep Sreevalsan, Marietta Döring, Maciej Paszkowski-Rogacz, et al.
Scientific Reports|June 9, 2017
A highly conserved sequence of the viral TAP inhibitor ICP47 is required for freezing of the peptide transport cycleTony Matschulla, Richard Berry, Carolin Gerke, et al.
International Immunopharmacology|June 24, 2021
Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapyMina Bahrololoumi Shapourabadi, Frank Momburg, Farzin Roohvand, et al.
Journal of Virology|June 12, 2009
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidaseMostafa Jarahian, Carsten Watzl, Philippe Fournier, et al.
Reports of Biochemistry & Molecular Biology|August 22, 2020
Expression and Purification of a Bispecific Antibody against CD16 and Hemagglutinin Neuraminidase (HN) in <i>E. Coli</i> for Cancer ImmunotherapyMina Bahrololoumi Shapourabadi, Farzin Roohvand, Arash Arashkia, et al.
Journal of Virology|January 21, 2011
Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcriptionAnne Halenius, Sebastian Hauka, Lars Dölken, et al.
Human Immunology|February 1, 2003
HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysisMatthias Ulbrecht, Valeska Hofmeister, Gülnihål Yüksekdag, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Immunology|May 21, 2022
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-EClaire Battin, Gabriel Kaufmann, Judith Leitner, et al.
Cancers|January 8, 2025
Reversal of Endothelial Cell Anergy by T Cell-Engaging Bispecific AntibodiesMárcia Gonçalves, Karsten M Warwas, Marten Meyer, et al.
Plos One|November 7, 2008
The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1Irini Evnouchidou, Frank Momburg, Athanasios Papakyriakou, et al.
EMBO Reports|October 16, 2020
MLLT6 maintains PD-L1 expression and mediates tumor immune resistanceSandeep Sreevalsan, Marietta Döring, Maciej Paszkowski-Rogacz, et al.
Scientific Reports|June 9, 2017
A highly conserved sequence of the viral TAP inhibitor ICP47 is required for freezing of the peptide transport cycleTony Matschulla, Richard Berry, Carolin Gerke, et al.
International Immunopharmacology|June 24, 2021
Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapyMina Bahrololoumi Shapourabadi, Frank Momburg, Farzin Roohvand, et al.
Journal of Virology|June 12, 2009
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidaseMostafa Jarahian, Carsten Watzl, Philippe Fournier, et al.
Reports of Biochemistry & Molecular Biology|August 22, 2020
Expression and Purification of a Bispecific Antibody against CD16 and Hemagglutinin Neuraminidase (HN) in <i>E. Coli</i> for Cancer ImmunotherapyMina Bahrololoumi Shapourabadi, Farzin Roohvand, Arash Arashkia, et al.
Journal of Virology|January 21, 2011
Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcriptionAnne Halenius, Sebastian Hauka, Lars Dölken, et al.
Human Immunology|February 1, 2003
HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysisMatthias Ulbrecht, Valeska Hofmeister, Gülnihål Yüksekdag, et al.
Pageof 7